A

BioSyent Inc. RX.V

TSX
Recommendation
Dividend Power Score
Day's Range
$16.61$16.92
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

RX.V Rating

Reward
Risk

RX.V Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

RX.V Company Overview

BioSyent Inc. is a Canadian specialty pharmaceutical company focused on the commercialization, licensing, and marketing of prescription pharmaceutical products, over-the-counter healthcare products, and medical devices. The company primarily operates in the healthcare and pharmaceutical sectors, with a business model centered on acquiring or licensing products for commercialization in Canada and selected international markets. Its revenue is primarily generated through sales of specialty pharmaceutical brands, particularly in iron deficiency, women’s health, allergy, and pediatric healthcare categories.

The company’s core operations are organized around branded healthcare products marketed through healthcare professionals, pharmacies, and distribution partners. BioSyent has built a niche position by targeting under-served therapeutic categories and leveraging regulatory, marketing, and distribution capabilities rather than engaging in large-scale pharmaceutical research and development. Founded in 2006 and headquartered in Toronto, Canada, the company evolved from a small healthcare commercialization platform into a profitable specialty pharmaceutical business through strategic product acquisitions, licensing agreements, and targeted expansion into international markets.

Data compiled by narrative technology. May contain errors.
Sector

RX.V Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

RX.V Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

RX.V Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

RX.V Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

RX.V Valuation

Market Cap
Market Cap Rank
#10,602
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

RX.V Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

RX.V Corporate Info

Phone Number
905-206-0013
Address
2476 Argentia Road
Suite 402
Mississauga, ON L5N 6M1
Country
Year Founded

RX.V Filings

Filing Date
Thursday, August 20, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 16 and 20 (est)

RX.V Headlines

There are no news to display.